Pura Vida Investments

Portfolio · 3

DarioHealth

Digital Therapeutics for Treating Chronic Conditions

1 round $70.0M committed Latest: 2021-01

V-Wave

Miniature Shunt for Treating Congestive Heart Failure

2 rounds $126.0M committed Latest: 2020-09

Motus GI

Colon Cleansing for Colonoscopy

1 round $30.0M committed Latest: 2017-02

Investment activity

2 portfolio exits on record.

Q&A

What is Pura Vida Investments' primary investment focus?

Pura Vida Investments primarily focuses on the Health Tech & Life Sciences sector, with all three of its listed portfolio companies and both of its exits being in this area.

Can you name a recent exit for Pura Vida Investments?

Pura Vida Investments had an exit in August 2024 when its portfolio company V-Wave, which develops miniature shunts for treating congestive heart failure, was acquired by Johnson & Johnson for $600M.

Which of Pura Vida Investments' portfolio companies are publicly traded?

Pura Vida Investments has two publicly traded portfolio companies: DarioHealth, which focuses on digital therapeutics for chronic conditions, and Motus GI, which specializes in colon cleansing for colonoscopies.

What was a notable exit for Pura Vida Investments in the past?

In February 2018, Pura Vida Investments saw its portfolio company Motus GI go public on NASDAQ, raising $17.5M in capital.

What is the investment stage breakdown for Pura Vida Investments?

Pura Vida Investments has participated in various stages, including a B Round, a C Round follow-on, and a PIPE round.